Study to improve outcomes in osteosarcoma care through collaboration
Part of Cancer clinical trials.
This trial focuses on improving how osteosarcoma care is coordinated and delivered, using collaboration between clinicians. It may help by helping teams make more consistent treatment decisions for people newly diagnosed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of osteosarcoma (bone cancer) confirmed by pathology/biopsy and scan findings
- If osteoid (a specific bone tissue finding) isn’t seen, your overall test results still strongly suggest osteosarcoma
- The diagnosis should be no more than 4 months before you register
- You (or your parent/legal guardian) can provide written consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects health and medical history from people with osteosarcoma and related bone cancers. It may help researchers learn how these cancers behave and support better future studies.
This study asks people with osteosarcoma about what it’s like to join and participate in clinical trials. It may help improve how future trials are explained and run.
This trial combines four targeted drugs (gefitinib, trametinib, disulfiram, sunitinib) with standard chemotherapy to treat osteosarcoma that has spread or come back. The goal is to see if this drug mix helps shrink tumors or keep them from growing.
This early-phase study tests whether adding losartan to sunitinib can help control osteosarcoma that has returned or keeps growing after at least one prior treatment. It may help by targeting the cancer’s growth signals and blood supply, but the goal at this stage is mainly to check safety and find workable dosing.
This trial studies the immune environment of osteosarcoma tumors to find more personalized treatments. It may help researchers understand why some treatments work better for certain patients.
This trial uses a lab-grown mini tumor (organoid) from your biopsy to test which drugs might work best for your osteosarcoma. It aims to personalize your treatment based on how your specific cancer cells respond.
Hear when a new Osteosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.